<bill session="113" type="h" number="5614" updated="2016-10-25T16:16:58Z">
  <state datetime="2014-09-18">REFERRED</state>
  <status>
    <introduced datetime="2014-09-18"/>
  </status>
  <introduced datetime="2014-09-18"/>
  <titles>
    <title type="short" as="introduced">United States Anti-Doping Agency Reauthorization Act</title>
    <title type="official" as="introduced">To reauthorize the United States Anti-Doping Agency, and for other purposes.</title>
    <title type="display">United States Anti-Doping Agency Reauthorization Act</title>
  </titles>
  <sponsor bioguide_id="J000292"/>
  <cosponsors>
    <cosponsor bioguide_id="T000469" joined="2014-09-18"/>
  </cosponsors>
  <actions>
    <action datetime="2014-09-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2014-09-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2014-09-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="113" relation="identical" number="2338"/>
  </relatedbills>
  <subjects>
    <term name="Sports and recreation"/>
    <term name="Athletes"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Olympic games"/>
  </subjects>
  <amendments/>
  <summary date="2014-09-18T04:00:00Z" status="Introduced in House">United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</summary>
  <committee-reports/>
</bill>
